Skip to main content
Premium Trial:

Request an Annual Quote

Alexander Bearn Dies

Alexander Bearn, a pioneer in the field of human biochemical genetics, died of heart failure at the age of 86. Bearn determined that Wilson's disease, which is marked by a buildup of copper in organs, is genetic and is caused by a recessive trait, reports the New York Times. Bearn worked at the Rockefeller Institute for Medical Research and Cornell University Medical College before moving into industry. He retired from Merck in 1988. "He was one of the pioneers of the application of genetics to medicine," says the University of Washington's Arno Motulsky.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.